Search results
Results from the WOW.Com Content Network
Depending on the facility's workflow most modalities send to a quality assurance (QA) workstation or sometimes called a PACS gateway. The QA workstation is a checkpoint to make sure patient demographics are correct as well as other important attributes of a study. If the study information is correct the images are passed to the archive for storage.
Emergency Medical Technician - Intermediate (OLD) EMT-P: Emergency Medical Technician - Paramedic (OLD) EN: Enrolled nurse (AU) – See Licensed practical nurse: EORTC: European Organization for Research Treatment in Cancer EpSSG: European paediatric soft tissue sarcoma study group ESRD: End Stage Renal Disease Program
A study plan on which all clinical trials are based. The plan is carefully designed to safeguard the health of the participants as well as answer specific research questions. A protocol describes what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study.
One explanation could be that nurses and physicians are insufficiently knowledgeable to adequately interpret the PA catheter measurements. Also, the benefits might be reduced by the complications from the use of the PAC. Furthermore, using information from the PAC might result in a more aggressive therapy causing the detrimental effect.
Primary airport control station, a survey marker established in the vicinity of an airport; Personal access control system.Gates, barriers and turnstiles that provide security for restricted areas on buildings and sites.
AOL Mail is free and helps keep you safe. From security to personalization, AOL Mail helps manage your digital life Start for free
Longer intervals as determined by the study protocol may also be appropriate. In the case of SD, follow-up measurements must have met the SD criteria at least once after study entry at a minimum interval (in general, not less than 6–8 weeks) that is defined in the study protocol; Duration of overall response
PAC-1 was discovered in Professor Paul Hergenrother's laboratory at the University of Illinois at Urbana–Champaign during a process that screened many chemicals for anti-tumor potential. This molecule, when delivered to cancer cells, signals the cells to self-destruct by activating an "executioner" protein, procaspase-3. Then, the activated ...